Literature DB >> 6093068

Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.

L E Davis, D G Burstyn, C R Manclark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6093068     DOI： 10.1097/00006454-198409000-00015

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN： 0277-9730


× No keyword cloud information.
  6 in total

1.  Neurological complications in hospitalized patients with pertussis: a 15-year Sicilian experience.

Authors:  G Incorpora; L Pavone; E Parano; M Cocuzza; F Catalano; R Trifiletti
Journal:  Childs Nerv Syst       Date:  1996-06       Impact factor: 1.475

Review 2.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Reading attainment and physical development after whooping cough.

Authors:  I D Johnston; H R Anderson; H P Lambert; S Patel
Journal:  J Epidemiol Community Health       Date:  1985-12       Impact factor: 3.710

4.  Central hypoventilation in a seven year old child following pertussis treated with negative pressure ventilation.

Authors:  D L Russell-Jones; D F Treacher; H M Lenicker; M Tashanov; G T Spencer
Journal:  Postgrad Med J       Date:  1989-10       Impact factor: 2.401

5.  Cognitive Development One Year After Infantile Critical Pertussis.

Authors:  John T Berger; Michele E Villalobos; Amy E Clark; Richard Holubkov; Murray M Pollack; Robert A Berg; Joseph A Carcillo; Heidi Dalton; Rick Harrison; Kathleen L Meert; Christopher J L Newth; Thomas P Shanley; David L Wessel; Kanwaljeet J S Anand; Jerry J Zimmerman; Ronald C Sanders; Teresa Liu; Jeri S Burr; Douglas F Willson; Allan Doctor; J Michael Dean; Tammara L Jenkins; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2018-02       Impact factor: 3.624

6.  Bordetella Dermonecrotic Toxin Is a Neurotropic Virulence Factor That Uses CaV3.1 as the Cell Surface Receptor.

Authors:  Shihono Teruya; Yukihiro Hiramatsu; Keiji Nakamura; Aya Fukui-Miyazaki; Kentaro Tsukamoto; Noriko Shinoda; Daisuke Motooka; Shota Nakamura; Keisuke Ishigaki; Naoaki Shinzawa; Takashi Nishida; Fuminori Sugihara; Yusuke Maeda; Yasuhiko Horiguchi
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.